Specifically, analysis using the GEPIA database revealed that BAG3 mRNA expression is higher in tumors compared to normal tissues across multiple cancers, including HNSCC, and that elevated BAG3 levels are associated with poorer clinical outcomes [28]. This evidence concerns the gene BAG3 and head and neck squamous cell carcinoma.